AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

ASTRAZEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-3.7%1-day move

₹8367.00

prior close

₹8431.50

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-1.1-1.3-1.1-0.6-3.7-1.6+0.4+2.5+1.6+0.4+2.5+4.3-1.5—

Up moveDown movePending

AI summary

AstraZeneca Pharma India has filed a routine regulatory compliance certificate confirming adherence to SEBI's Depositories and Participants Regulations. The certificate from their Registrar and Transfer Agent, Integrated Registry Management Services, covers the period March 1-31, 2026 and verifies that dematerialization requests were processed correctly. The RTA confirmed that securities dematerialized were properly listed, mutilated certificates were canceled, and the depository's name was updated as the registered owner. This is a standard periodic filing required under Regulation 74(5), which mandates RTA confirmation within 15 days of receiving dematerialization certificates from depository participants.

Likely market impact

No direct impact on shareholders or stock price. This is a routine compliance filing that confirms proper administrative handling of share dematerialization during March 2026. It does not indicate any corporate action or material change in the company's operations.